Jitian Li | Semantic Scholar

Publications
Influence

Claim Your Author Page

Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications.

Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens

Liping Dai, Jitian Li, Rosalia Ortega, Wei Qian, Carlos A Casiano, Jian-Ying Zhang
Journal of immunology research
2014

Previous studies have demonstrated that sera from patients with prostate cancer (PCa) contain autoantibodies that react with tumor-associated antigens (TAAs). Autoantibodies to cyclin B1 and fourteen… (More)

Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.

Liping Dai, Jitian Li, Mengtao Xing, Tino W. Sanchez, Carlos A Casiano, Jian-Ying Zhang
The Prostate
2016

BACKGROUND The prostate-specific antigen (PSA) testing has been widely implemented for the early detection and management of prostate cancer (PCa). However, the lack of specificity has led to… (More)

Autoantibodies against tumor-associated antigens in the early detection of lung cancer.

Liping Dai, Jun-Chieh J Tsay, +7 authors Jian-Ying Zhang
Lung cancer
2016

OBJECTIVES Autoantibodies against tumor-associated antigens (TAAs) identified in patients with advanced lung cancer may be detected in subjects with early lung cancer or even predate the diagnosis.… (More)

Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma

Mei Liu, Armando Varela-Ramirez, Jitian Li, Liping Dai, Renato J. Aguilera, Jian-Ying Zhang
Oncology reports
2015

Hepatocellular carcinoma (HCC) is a worldwide prevalent cancer with an exremely poor prognosis. Detection of serum α-fetoprotein (AFP) and liver imaging techniques are the conventional methods used… (More)

Dose reduction of recombinant human tumor necrosis factor inhibitors (etanercept) can be effective in ankylosing spondylitis patients with synovitis of the hip in a Chinese population

Jitian Li, Xiaoqing Wang, +4 authors Wuyin Li
International journal of immunopathology and…
2016

Ankylosing spondylitis (AS) is an immune-mediated inflammatory arthritis and enthesitis involving the spine and peripheral joints. In recent years, specific antagonist of tumor necrosis factor… (More)

Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis

Xinxin Liu, Yurong Chai, +6 authors Jian-Ying Zhang
Tumor Biology
2013

There is an urgent need to identify relevant tumor markers showing high sensitivity and specificity for early immunodiagnosis of breast cancer. Autoantibodies directed against tumor-associated… (More)

Mei Liu, Xinxin Liu, +7 authors Jian-Ying Zhang
Tumor Biology
2013

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. Serum alpha-fetoprotein (AFP) is the conventional biomarker currently… (More)

Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.

Tino W. Sanchez, Guangyu Zhang, +8 authors Carlos A Casiano
Molecular & cellular proteomics : MCP
2016

African American (AA) men suffer from a disproportionately high incidence and mortality of prostate cancer (PCa) compared with other racial/ethnic groups. Despite these disparities, African American… (More)

Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of…

Liping Dai, Yanhong Qu, +5 authors Jianying Zhang
Oncotarget
2017

PURPOSE Lung cancer (LC) is the leading cause of cancer-related deaths for both male and female worldwide. Early detection of LC could improve five-year survival rate up to 48.8% compared to 3.3% of… (More)

ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.

Xiaochuan Su, Junyan Teng, +10 authors Qing Guo
Biomedicine & pharmacotherapy = Biomedecine…
2019

Osteosarcoma (OS) is the commonest malignant bone tumor in the world. High incidence of OS has gradually become a social problem. Recent years, numerous studies have revealed that long non-coding… (More)